HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): A. Marc Gillinov Duke E. Cameron Peter W. Cho Peter S. Greene Bruce A. Reitz Vincent L. Gott Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gillinov, A. M. Articles by Gott, V. L. Search for Related Content PubMed PubMed Citation Articles by Gillinov, A. M. Articles by Gott, V. L.

J Thorac Cardiovasc Surg 1994;107:724-731
© 1994 Mosby, Inc.

SURGERY FOR ACQUIRED HEART DISEASE

Mitral valve operation in patients with the Marfan syndrome

Baltimore, Md.

Supported by U.S. Public Health Service National Institutes of Health grant HL35877 and the National Marfan Foundation.

Presented in part at the Forty-Second Annual Scientific Session of the American College of Cardiology, Anaheim, Calif., March 14-18, 1993.

Received for publication April 20, 1993. Accepted for publication Aug. 17, 1993. Address for reprints: Duke E. Cameron, MD, The Johns Hopkins Hospital, 600 N. Wolfe St.—Blalock 618, Baltimore, MD 21287.

Abstract

Optimal surgical treatment of mitral regurgitation in the Marfan syndrome (valve repair versus replacement) is controversial because the underlying connective tissue defect theoretically might compromise repair durability. To examine the results of mitral valve repair in these patients, we did a retrospective review of 160 patients with the Marfan syndrome who had cardiac surgical procedures between January 1983 and January 1993. Thirty-six patients had mitral procedures, 29 of which were repairs. Mitral valve replacement was necessary in seven patients because of extensive annular calcification and/or severe anterior leaflet abnormalities. The 18 men and 11 women undergoing mitral valve repair had a mean age of 26.5 ± 2.6 years (range 9 months to 54 years); seven patients were less than 18 years of age. Twenty-four of the 29 patients had concomitant aortic root replacement because of aortic dilation or valvular insufficiency. All 29 repairs included annuloplasty, and 11 patients also required leaflet resection. There were no operative deaths. At mean follow-up of 26.6 ± 4.8 months, there have been three late deaths, two caused by arrhythmia and one by complications of type III aortic dissection. All survivors are in New York Heart Association class I or II. In three patients recurrent mitral regurgitation developed (grade III or IV); 5-year actuarial freedom from significant mitral regurgitation was 88.3%. One patient required repeat mitral annuloplasty after endocarditis of the composite aortic graft spread to the mitral valve. No patient required late mitral valve replacement. These results demonstrate that (1) 22% of patients with the Marfan syndrome who undergo cardiac operation require a mitral valve procedure, (2) most can be treated by mitral repair rather than replacement, and (3) at early follow-up, results of mitral repair in this population are satisfactory. (J THORACCARDIOVASCSURG1994;107:724-31)

This article has been cited by other articles:

				R. E Pyeritz Marfan syndrome: 30 years of research equals 30 years of additional life expectancy Heart, February 1, 2009; 95(3): 173 - 175. [Full Text] [PDF]

				H. V. Schaff and R. M. Suri Multiple Valve Disease Card. Surg. Adult, January 1, 2008; 3(2008): 1129 - 1158. [Full Text]

				D. R. Brinster, R. J. Rizzo, and R. M. Bolman III Ascending Aortic Aneurysms Card. Surg. Adult, January 1, 2008; 3(2008): 1223 - 1250. [Full Text]

				S. K. Bhudia, R. Troughton, B.-K. Lam, J. Rajeswaran, W. R. Mills, A. M. Gillinov, B. P. Griffin, E. H. Blackstone, B. W. Lytle, and L. G. Svensson Mitral Valve Surgery in the Adult Marfan Syndrome Patient Ann. Thorac. Surg., March 1, 2006; 81(3): 843 - 848. [Abstract] [Full Text] [PDF]

				T. Goto, J. Kobayashi, H. Nakajima, K. Niwaya, O. Tagusari, and S. Kitamura Mitral Valve Repair and Cryo-Maze Procedure in Ehlers-Danlos Syndrome Asian Cardiovasc Thorac Ann, June 1, 2005; 13(2): 181 - 183. [Abstract] [Full Text] [PDF]

				H. Nakajima, K. Bando, S. Kitamura, J. Kobayashi, K. Niwaya, and O. Tagusari Maze procedure in the Marfan syndrome J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1539 - 1540. [Full Text] [PDF]

				H. V. Schaff and D. H. Marsh Multiple Valve Disease Card. Surg. Adult, January 1, 2003; 2(2003): 1017 - 1045. [Full Text]

				C. A. Anderson, R. J. Rizzo, and L. H. Cohn Ascending Aortic Aneurysms Card. Surg. Adult, January 1, 2003; 2(2003): 1123 - 1148. [Full Text]

				J.-F. G. Fuzellier, S. M. Chauvaud, P. Fornes, A. J. Berrebi, P. S. Lajos, P. Bruneval, and A. F. Carpentier Surgical management of mitral regurgitation associated with marfan's syndrome Ann. Thorac. Surg., July 1, 1998; 66(1): 68 - 72. [Abstract] [Full Text] [PDF]

				V. L. Gott Invited commentary Ann. Thorac. Surg., July 1, 1998; 66(1): 72 - 72. [Full Text] [PDF]

				A. M. Gillinov, K. J. Zehr, J. M. Redmond, V. L. Gott, H. C. Deitz, B. A. Reitz, J. C. Laschinger, and D. E. Cameron Cardiac Operations in Children With Marfan's Syndrome: Indications and Results Ann. Thorac. Surg., October 1, 1997; 64(4): 1140 - 1144. [Abstract] [Full Text]